Karyopharm Therapeutics, Inc. (KPTI)
9.06
+0.37
(+4.26%)
USD |
NASDAQ |
Jun 10, 16:00
8.93
-0.13
(-1.43%)
After-Hours: 17:27
Karyopharm Therapeutics EPS Diluted (TTM) : -15.09 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -15.09 |
| December 31, 2025 | -16.62 |
| September 30, 2025 | -14.58 |
| June 30, 2025 | -11.02 |
| March 31, 2025 | -6.893 |
| December 31, 2024 | -4.446 |
| September 30, 2024 | -1.143 |
| June 30, 2024 | -1.188 |
| March 31, 2024 | -1.275 |
| December 31, 2023 | -1.252 |
| September 30, 2023 | -1.316 |
| June 30, 2023 | -1.468 |
| March 31, 2023 | -1.798 |
| December 31, 2022 | -2.031 |
| September 30, 2022 | -1.157 |
| June 30, 2022 | -1.391 |
| March 31, 2022 | -1.487 |
| December 31, 2021 | -1.724 |
| September 30, 2021 | -2.759 |
| June 30, 2021 | -2.800 |
| March 31, 2021 | -2.722 |
| December 31, 2020 | -2.734 |
| September 30, 2020 | -2.906 |
| June 30, 2020 | -2.844 |
| March 31, 2020 | -2.923 |
| Date | Value |
|---|---|
| December 31, 2019 | -3.227 |
| September 30, 2019 | -3.424 |
| June 30, 2019 | -3.551 |
| March 31, 2019 | -3.439 |
| December 31, 2018 | -3.127 |
| September 30, 2018 | -2.969 |
| June 30, 2018 | -2.825 |
| March 31, 2018 | -11.83 |
| December 31, 2017 | -21.76 |
| September 30, 2017 | -21.61 |
| June 30, 2017 | -21.65 |
| March 31, 2017 | -12.89 |
| December 31, 2016 | -2.93 |
| September 30, 2016 | -3.09 |
| June 30, 2016 | -3.25 |
| March 31, 2016 | -3.33 |
| December 31, 2015 | -3.32 |
| September 30, 2015 | -3.30 |
| June 30, 2015 | -3.06 |
| March 31, 2015 | -2.69 |
| December 31, 2014 | -2.41 |
| September 30, 2014 | -2.34 |
| June 30, 2014 | -2.043 |
| March 31, 2014 | -1.493 |
| December 31, 2013 | -1.033 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Gilead Sciences, Inc. | 7.349 |
| Catalyst Pharmaceuticals, Inc. | 1.740 |
| Incyte Corp. | 7.072 |
| Inovio Pharmaceuticals, Inc. | -1.708 |
| Cellectar Biosciences, Inc. | -7.374 |